greeksoup/ stock research

Cardinal Health (CAH) FY2024 results: revenue $226.8 billion, up 10.6% on the year

Cardinal Health Inc. (CAH) reported revenue of $226.8 billion for fiscal 2024, the year ended 30 June 2024, up 10.6% on the year before. Net income was $852 million, up 158.2%, and diluted earnings per share $3.45. The figures are the company's own, from the 10-K it filed with the SEC on 14 August 2024.

Revenue
$226.8 billion
+10.6% on the year
FY2017FY2024
Operating margin
0.5%
0.4% a year earlier
FY2017FY2024
Net income
$852 million
+158.2% on the year
FY2017FY2024
Diluted EPS
$3.45
+173.8% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue226,827205,012181,364+10.6%
Cost of revenue219,413198,123174,819+10.7%
Gross profit7,4146,8746,484+7.9%
Gross margin3.3%3.4%3.6%
Selling, general and administrative5,0004,8004,512+4.2%
Operating income1,243752-607+65.3%
Operating margin0.5%0.4%-0.3%
Interest expense51.084.0147-39.3%
Pre-tax income1,201663-784+81.1%
Income tax348332153+4.8%
Effective tax rate29.0%50.1%n/a
Net income852330-938+158.2%
Net margin0.4%0.2%-0.5%
Diluted EPS$3.45$1.26-$3.37+173.8%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow3,7622,8393,175+32.5%
Capital expenditure511481387+6.2%
Free cash flow3,2512,3582,788+37.9%
Free cash flow margin1.4%1.2%1.5%
Cash from investing-1,849-454567
Cash from financing-847-3,051-2,463
Depreciation and amortisation710692692+2.6%
Share-based compensation12196.081.0+26.0%
Buybacks7502,0001,000-62.5%
Dividends paid499525559-5.0%
Dividend per share$2.00$1.98$1.96+1.0%
Diluted shares, weighted247m262m279m-5.7%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity-3,213-2,958-709
Non-controlling interest1.01.03.00.0%
Debt5,1004,7005,300+8.5%
Operating lease liabilities400375388+6.7%
Finance lease liabilities75.059.049.0+27.1%
Other liabilities42,75841,24038,847+3.7%
Total liabilities and equity45,12143,41743,878+3.9%
Fixed assets2,5292,4622,361+2.7%
Goodwill4,7254,6095,855+2.5%
Intangible assets1,7251,4721,774+17.2%
Investments200n/an/a
Cash and equivalents5,1334,0764,717+25.9%
Receivables12,08411,10810,561+8.8%
Inventory14,95716,11915,636-7.2%
Other assets3,7683,5712,974+5.5%
Total assets45,12143,41743,878+3.9%

10-K for the year ended 30 June 2024, filed 14 August 2024: the filing.